Fulcrum Asset Management LLP lifted its position in Bath & Body Works, Inc. (NYSE:BBWI – Free Report) by 12,067.0% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 27,984 shares of the company’s stock after acquiring an additional 27,754 shares during the quarter. Fulcrum Asset Management LLP’s holdings in Bath & Body Works were worth $447,000 as of its most recent SEC filing.
Other institutional investors have also made changes to their positions in the company. Elevation Wealth Partners LLC raised its position in shares of Bath & Body Works by 5,278.8% during the 2nd quarter. Elevation Wealth Partners LLC now owns 1,775 shares of the company’s stock valued at $41,000 after acquiring an additional 1,742 shares in the last quarter. Parallel Advisors LLC lifted its stake in Bath & Body Works by 35.5% during the first quarter. Parallel Advisors LLC now owns 2,570 shares of the company’s stock worth $48,000 after purchasing an additional 673 shares during the last quarter. Meeder Asset Management Inc. bought a new position in Bath & Body Works during the second quarter worth $66,000. Global Retirement Partners LLC acquired a new position in Bath & Body Works in the second quarter worth $71,000. Finally, Mirae Asset Global Investments Co. Ltd. acquired a new position in Bath & Body Works in the third quarter worth $72,000. 95.14% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several analysts have weighed in on the stock. UBS Group boosted their target price on shares of Bath & Body Works from $17.00 to $22.00 and gave the company a “neutral” rating in a research note on Friday. Citigroup upgraded shares of Bath & Body Works from a “neutral” rating to a “buy” rating and set a $25.00 price target on the stock in a research report on Tuesday, August 18th. Jefferies Financial Group lifted their price target on shares of Bath & Body Works from $22.00 to $23.00 and gave the company a “hold” rating in a report on Tuesday, July 28th. Morgan Stanley lowered their price objective on shares of Bath & Body Works from $22.00 to $20.00 and set an “equal weight” rating for the company in a research report on Thursday, August 27th. Finally, BMO Capital Markets began coverage on shares of Bath & Body Works in a research note on Tuesday, September 8th. They set a “market perform” rating and a $20.00 price objective on the stock. Four equities research analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, Bath & Body Works currently has an average rating of “Hold” and a consensus price target of $22.53.
View Our Latest Analysis on BBWI
Bath & Body Works Trading Down 0.2%
Shares of NYSE:BBWI opened at $21.36 on Monday. The firm’s 50 day moving average is $19.21 and its two-hundred day moving average is $19.82. The firm has a market capitalization of $4.31 billion, a P/E ratio of 5.56, a PEG ratio of 1.07 and a beta of 1.31. Bath & Body Works, Inc. has a 52 week low of $14.27 and a 52 week high of $24.94.
Bath & Body Works (NYSE:BBWI – Get Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The company reported $0.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.24 by $0.38. Bath & Body Works had a negative return on equity of 53.48% and a net margin of 10.83%. The business had revenue of $1.51 billion during the quarter, compared to the consensus estimate of $1.50 billion. During the same period in the previous year, the firm posted $0.30 earnings per share. The business’s revenue was down 2.3% on a year-over-year basis. Bath & Body Works has set its Q3 2026 guidance at 0.070-0.120 EPS and its FY 2026 guidance at 2.600-2.800 EPS. Analysts predict that Bath & Body Works, Inc. will post 2.74 EPS for the current year.
Bath & Body Works Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 4th. Stockholders of record on Friday, November 20th will be paid a $0.20 dividend. The ex-dividend date of this dividend is Friday, November 20th. This represents a $0.80 annualized dividend and a dividend yield of 3.7%. Bath & Body Works’s dividend payout ratio is presently 20.83%.
Bath & Body Works Profile
Bath & Body Works, Inc. is a specialty retailer focused on personal care and home fragrance products. Its offerings include body lotions, soaps, fragrances, hand sanitizers, candles and other home-fragrance items, sold under the Bath & Body Works and White Barn brands. The company serves customers through its stores and e-commerce platform in the United States and Canada, as well as through international franchise, license and wholesale partners. Bath & Body Works traces its roots to a store launched in 1990.
Recommended Stories
- Five stocks we like better than Bath & Body Works
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding BBWI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWI – Free Report).
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.
